  0 Table of Contents |
  1 Home |
| 2 Participant |
| 3 Consent |
| 4 Documents |
| 5 Sites and people |
| 6 Study and participation |
| 7 Visit and measurement |
 8 Artifacts Summary |
 8.1 Healthy Route Blood Pressure |
| 8.2 Healthy Route Consent |
| 8.3 Healthy Route Consent Evidence |
| 8.4 Healthy Route Document |
| 8.5 Healthy Route Investigation Request |
| 8.6 Healthy Route Laboratory Report |
| 8.7 Healthy Route Location |
| 8.8 Healthy Route Measurement |
| 8.9 Healthy Route Organization |
| 8.10 Healthy Route Patient |
| 8.11 Healthy Route Patient (Export) |
| 8.12 Healthy Route Practitioner |
| 8.13 Healthy Route Reported Condition |
| 8.14 Healthy Route Reported Medicine |
| 8.15 Healthy Route Retinal Imaging |
| 8.16 Healthy Route Sample |
| 8.17 Healthy Route Screening Visit |
| 8.18 Healthy Route Study |
| 8.19 Healthy Route Study Participation |
| 8.20 Age in Years |
| 8.21 Reading Device |
| 8.22 Reading Position |
| 8.23 Reading Sequence |
| 8.24 Tenant |
| 8.25 Blood Pressure Monitors Value Set |
| 8.26 Blood Pressure Reading Position Value Set |
| 8.27 Consent Permission Value Set |
| 8.28 Dose Form Value Set |
| 8.29 Eye Value Set |
| 8.30 Frequency Scale Value Set |
| 8.31 Laboratory Units Value Set |
| 8.32 Medicine Frequency Value Set |
| 8.33 Medicine Route Value Set |
| 8.34 Physical Activity at Work Value Set |
| 8.35 Reactive or Non-reactive Value Set |
| 8.36 Urine Dipstick Protein Value Set |
| 8.37 Use Status Value Set |
| 8.38 Visit Part Value Set |
| 8.39 Blood Pressure Monitors |
| 8.40 Blood Pressure Reading Position |
| 8.41 Consent Permission |
| 8.42 Dose Form |
| 8.43 Eye |
| 8.44 Frequency Scale |
| 8.45 Healthy Route Measurement Codes |
| 8.46 Medicine Frequency |
| 8.47 Medicine Route |
| 8.48 Physical Activity at Work |
| 8.49 Reactive or Non-reactive |
| 8.50 Urine Dipstick Protein Scale |
| 8.51 Use Status |
| 8.52 Visit Part |
| 8.53 Blood pressure, derived value |
| 8.54 Blood pressure, first reading |
| 8.55 Blood pressure, second reading |
| 8.56 Blood pressure, third reading |
| 8.57 Blood sample |
| 8.58 eGFR by CKD-EPI 2021 |
| 8.59 Example consent to study participation |
| 8.60 Example general out-patient clinic |
| 8.61 Example participant |
| 8.62 Example participation ending in screen failure |
| 8.63 Example renal clinic |
| 8.64 Example screening visit |
| 8.65 Example study site |
| 8.66 Example study team member |
| 8.67 Example study, country A |
| 8.68 Example study, country B |
| 8.69 Example visit part: imaging |
| 8.70 Example visit part: samples |
| 8.71 HbA1c |
| 8.72 History: diabetes, as reported |
| 8.73 History: tobacco smoking status |
| 8.74 Laboratory report |
| 8.75 Reported condition: diabetes |
| 8.76 Reported medicine: amlodipine |
| 8.77 Request for laboratory investigations |
| 8.78 Retinal photography, both eyes |
| 8.79 Serum creatinine |
| 8.80 Urine albumin-to-creatinine ratio |
| 8.81 Urine dipstick protein |
 8.82 Urine sample |